CNS & Neurology
Clinical trials in CNS and neurological disorders demand exceptional precision, consistency, and patient understanding. At UNIQ, we recognize the complexity of the brain—and the profound impact these conditions have on patients’ lives.
Expert Clinical Solutions for Neurodegenerative Discoveries
Advancing complex science with dignity, clarity, and care.
At UNIQ, we bring deep CNS expertise and adaptive operational strategies to studies spanning a broad range of neurological and neurodegenerative disorders, as well as psychiatry and pain management. Our teams have a strong understanding of the inherent complexity of CNS research — including slow and competitive recruitment, sensitive and subjective endpoints, high inter- and intra-patient variability, and evolving regulatory expectations — and we design tailored solutions to address these challenges head-on.
With a strong focus on patient-centric execution, robust scientific oversight, and digitally enabled operations, we help sponsors navigate complexity while reducing risk and accelerating informed decision-making. Our approach integrates thoughtful protocol design, fit-for-purpose endpoint selection, and streamlined operational models to support efficient study conduct across regions.
Whether supporting early-phase, biomarker-driven programs or large, global development strategies, our neuroscience capabilities are built to deliver clarity, operational excellence, and high-quality data at every stage of development. We partner closely with sponsors to ensure that innovative therapies for neurodegenerative diseases, psychiatric conditions, movement disorders, and chronic pain are advanced with rigor, precision, and care.
Ready to take your neuroscience program to the next level?
Global Reach
15+ countries and 1,000 trial sites
Indication Breadth
15+ CNS disorders including rare disorders
Operational Expertise
40+ CNS trials across I-III phases
Comprehensive Phase I–IV Neuroscience Expertise
"Designed for Precision", "Built for Sponsors".
Neuroscience clinical development is one of the most complex and sensitive areas of research. At unIQ Trials, we support sponsors with end-to-end CRO services that combine scientific depth, operational discipline, and human-centered design.
Whether you’re advancing early-phase neurobiology, navigating rare neurological conditions, or scaling global late-phase programs, our teams deliver the precision, oversight, and flexibility needed to keep CNS studies moving forward.
Global Reach
15+ countries
and 1,000 trial sites
Indication Breadth
10+ CNS indications including rare disorders
Operational Expertise
40+ CNS studies supported across Phases I–IV
Precision Recruitment for Complex Neurology Populations
Recruiting and retaining CNS patients is one of the most challenging aspects of neurological research — especially when cognitive impairment, mobility limitations, or rare disease prevalence restrict access to traditional trial pathways.
At unIQ Trials, we combine data intelligence, patient-centric design, and global specialist networks to reach the right participants quickly and keep them engaged throughout the study.
Our Approach
Neurology-Focused Feasibility Modeling
We use historical site performance, prevalence mapping, genetic registry data, and protocol burden modeling to identify the most capable sites before activation.
Global Specialist Site Network
Prequalified sites across neurology centers, memory clinics, rare-disease programs, and DCT-ready hospitals.
Hybrid & Decentralized Participation Options
Telemedicine visits, digital cognitive assessments, wearable monitoring, and caregiver-supported workflows lower patient burden and improve compliance.
Caregiver & Family Engagement Plans
Specialized retention pathways for indications involving caregivers (Alzheimer’s, Huntington’s, pediatric neurology).